197 related articles for article (PubMed ID: 32469987)
21. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
Zhao S; Qiu Z; He J; Li L; Li W
Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.
Ma XL; Li YY; Zhang J; Huang JW; Jia HY; Liu L; Li P
Asian Pac J Cancer Prev; 2014; 15(15):6015-20. PubMed ID: 25124566
[TBL] [Abstract][Full Text] [Related]
24. High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas.
Yanagisawa N; Ichinoe M; Mikami T; Nakada N; Hana K; Koizumi W; Endou H; Okayasu I
J Clin Pathol; 2012 Nov; 65(11):1019-23. PubMed ID: 22813728
[TBL] [Abstract][Full Text] [Related]
25. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta-Analysis.
Xiao K; Xiao K; Li K; Xue P; Zhu S
J Immunol Res; 2021; 2021():5440572. PubMed ID: 34888386
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis.
Xu Y; Zhang Y; Wang X; Kang J; Liu X
BMC Cancer; 2019 Feb; 19(1):168. PubMed ID: 30795756
[TBL] [Abstract][Full Text] [Related]
28. Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Ogata S; Matsuo H; Kanai Y; Endou H; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Kawai T
Virchows Arch; 2007 Sep; 451(3):681-90. PubMed ID: 17622555
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis.
Zhang H; Gao L; Zhang B; Zhang L; Wang C
Sci Rep; 2016 Mar; 6():22618. PubMed ID: 26939789
[TBL] [Abstract][Full Text] [Related]
30. Comparison of L-type amino acid transporter 1 expression and L-[3-18F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer.
Kaira K; Oriuchi N; Shimizu K; Imai H; Tominaga H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Oyama T; Mori M; Endo K
Nucl Med Biol; 2010 Nov; 37(8):911-6. PubMed ID: 21055621
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Han W; Cao F; Chen MB; Lu RZ; Wang HB; Yu M; Shi CT; Ding HZ
PLoS One; 2016; 11(1):e0145803. PubMed ID: 26731428
[TBL] [Abstract][Full Text] [Related]
33. Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients.
Wan G; Xiang L; Sun X; Wang X; Li H; Ge W; Cao F
Oncotarget; 2017 Jan; 8(3):5382-5391. PubMed ID: 28036271
[TBL] [Abstract][Full Text] [Related]
34. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
[TBL] [Abstract][Full Text] [Related]
35. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
Ai B; Liu H; Huang Y; Peng P
Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
[TBL] [Abstract][Full Text] [Related]
36. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets.
Shao Y; Gu W; Ning Z; Song X; Pei H; Jiang J
Cell Physiol Biochem; 2017; 41(4):1468-1480. PubMed ID: 28351024
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Zhan B; Lu D; Luo P; Wang B
Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
[TBL] [Abstract][Full Text] [Related]
39. Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis.
Zhu H; Luo H; Zhu X; Hu X; Zheng L; Zhu X
Oncotarget; 2017 Jan; 8(1):1628-1640. PubMed ID: 27911861
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2009 Feb; 100(2):248-54. PubMed ID: 19068093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]